4-aminobenzoic acid has been researched along with ng-nitroarginine methyl ester in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boe, AE; Eren, M; Ichimura, A; Kamide, CE; McAnally, D; Miyata, T; Murphy, SB; Smith, LH; Terry, D; Vaughan, DE | 1 |
| Ha, H; Huh, JY; Jung, I; Miyata, T; Piao, L | 1 |
2 other study(ies) available for 4-aminobenzoic acid and ng-nitroarginine methyl ester
| Article | Year |
|---|---|
Plasminogen activator inhibitor-1 antagonist TM5441 attenuates Nω-nitro-L-arginine methyl ester-induced hypertension and vascular senescence.
Topics: Animals; Aorta; Blood Pressure; Cardiomegaly; Cellular Senescence; Drug Interactions; Enzyme Inhibitors; Female; Hypertension; Male; Mice; Mice, Inbred C57BL; NG-Nitroarginine Methyl Ester; para-Aminobenzoates; Piperazines; Rats; Rats, Wistar; Serpin E2; Structure-Activity Relationship; Telomere | 2013 |
A novel plasminogen activator inhibitor-1 inhibitor, TM5441, protects against high-fat diet-induced obesity and adipocyte injury in mice.
Topics: Adipocytes; Animals; Diet, High-Fat; Dose-Response Relationship, Drug; Mice; Mice, Inbred C57BL; NG-Nitroarginine Methyl Ester; Obesity; para-Aminobenzoates; Piperazines; Serpin E2; Structure-Activity Relationship | 2016 |